Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Raffi

Showing results (151-160 of 224) with videos related to

Pageof 23
Sort By:
Presse Medicale (Paris, France : 1983)|May 16, 1987
[Neuromeningeal listeriosis in adults, excluding pregnancy. Prognosis and development of neurologic manifestations. Retrospective study of 63 cases]P Choutet, J M Besnier, S Hurtault, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohortP Carrieri, V Cailleton, V Le Moing, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2012
High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugsC Allavena, C Delpierre, L Cuzin, et al.
Presse Medicale (Paris, France : 1983)|March 27, 1999
[Community-acquired bacterial meningitis in the Loire-Atlantic region: evolution of pneumococcal and meningococcal sensitivity to penicillin]L Struillou, E Ninin, C Berranger, et al.
Medecine Et Maladies Infectieuses|August 11, 2020
Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosisJ Brochard, F Morio, J Mahe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2000
Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNAF Raffi, B Bonnet, V Ferré, et al.
Plos One|September 7, 2019
Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat'AIDS cohortL Cuzin, L Cotte, C Delpierre, et al.
AIDS Care|October 18, 2011
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerabilityM Préau, C Protopopescu, F Raffi, et al.
The Journal of Antimicrobial Chemotherapy|April 4, 2017
Correction of myelotoxicity after switch of linezolid to tedizolid for prolonged treatmentsL Khatchatourian, A Le Bourgeois, N Asseray, et al.
AIDS Care|June 30, 2004
Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatmentM Préau, C Leport, D Salmon-Ceron, et al.
Pageof 23

Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
Presse Medicale (Paris, France : 1983)|May 16, 1987
[Neuromeningeal listeriosis in adults, excluding pregnancy. Prognosis and development of neurologic manifestations. Retrospective study of 63 cases]P Choutet, J M Besnier, S Hurtault, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohortP Carrieri, V Cailleton, V Le Moing, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2012
High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugsC Allavena, C Delpierre, L Cuzin, et al.
Presse Medicale (Paris, France : 1983)|March 27, 1999
[Community-acquired bacterial meningitis in the Loire-Atlantic region: evolution of pneumococcal and meningococcal sensitivity to penicillin]L Struillou, E Ninin, C Berranger, et al.
Medecine Et Maladies Infectieuses|August 11, 2020
Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosisJ Brochard, F Morio, J Mahe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2000
Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNAF Raffi, B Bonnet, V Ferré, et al.
Plos One|September 7, 2019
Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat'AIDS cohortL Cuzin, L Cotte, C Delpierre, et al.
AIDS Care|October 18, 2011
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerabilityM Préau, C Protopopescu, F Raffi, et al.
The Journal of Antimicrobial Chemotherapy|April 4, 2017
Correction of myelotoxicity after switch of linezolid to tedizolid for prolonged treatmentsL Khatchatourian, A Le Bourgeois, N Asseray, et al.
AIDS Care|June 30, 2004
Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatmentM Préau, C Leport, D Salmon-Ceron, et al.
Pageof 23